Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06174493

Investigating Participation Patterns of Patients in Atopic Dermatitis Clinical Trials

Clinical trials, specifically focused on atopic dermatitis, are crucial in assessing the safety and efficacy of new treatments. These trials serve as fundamental instruments in determining whether emerging medications outperform standard therapies, providing compelling evidence to support wider implementation.

The main goal is to thoroughly scrutinize trial completion rates and voluntary withdrawals among this particular group of patients.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Atopic Dermatitis Congenital, Hereditary, and Neonatal Diseases and Abnormalities Dermatitis Dermatitis, Atopic Genetic Diseases, Inborn Hypersensitivity Hypersensitivity, Immediate Immune System Diseases Skin Diseases Skin Diseases, Eczematous Skin Diseases, Genetic Skin and Connective Tissue Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Power Life Sciences

San Francisco, California, 94107, United States

Location contact

Michael B Gill

CONTACT

https://www.withpower.com/[email protected]

415-900-4227

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Ability to understand and the willingness to sign a written informed consent document
  • Participant must be 18 years of age or older
  • Confirmed diagnosis of atopic dermatitis

Exclusion criteria

  • Enrolled in another research study
  • Is pregnant, breastfeeding or expecting to conceive within the projected duration of the study
  • Inability to provide written informed consent

Treatment and study plan

Primary outcomes

  1. Number of atopic dermatitis patients who decide to enroll in a clinical research

    Time frame: 3 months

  2. Rate of atopic dermatitis patients who remain in clinical trial to trial completion

    Time frame: 12 months

Study contacts

Contact information is provided by the study sponsor or research team.

Michael B Gill

CONTACT

[email protected]

415-900-4227

Sponsors and collaborators

Lead sponsor

Power Life Sciences Inc.

Industry

Registry information

Official study title

Understanding Patient Engagement Trends in Atopic Dermatitis Clinical Research

Important dates

Study start
2025
Primary completion
2026
Study completion
2027
First posted
Dec 18, 2023
Registry last updated
Feb 12, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.